News
Related: Why drug stocks are no longer a safe haven from the stock market's turmoil "The power of Johnson & Johnson's uniquely diversified portfolio was on full display this quarter, with strong ...
Johnson & Johnson took a shot at the Trump administration’s tariff policy and outlined its plans for how it will absorb the negative impact. But even with the extra costs, which the medical ...
In the latest market close, Johnson & Johnson (JNJ) reached $163.29, with a -0.21% movement compared to the previous day. The stock's change was less than the S&P 500's daily gain of 1.77%.
At the time, the site’s top headline was about the stock market crash. SPOTTED: Speaker Johnson, on his phone and checking out the Drudge Report during Trump’s speech last night. The website ...
Behind declines for shares of Johnson & Johnson and Merck, the Dow Jones Industrial Average is declining Tuesday morning. Supported by world-class markets data from Dow Jones and FactSet ...
In this article, we are going to take a look at where Johnson & Johnson (NYSE ... Cramer noted that investors reacted to the Fed’s open market committee meeting results with the same old rhetoric.
And I think there’s sort of renewed ... Dusty Johnson, a leadership ally, arguing that the GOP needs to articulate its plans to grow the economy to help stave off market jitters.
Related: Why drug stocks are no longer a safe haven from the stock market's turmoil Speaking during a conference call to discuss the results, Johnson & Johnson Chief Financial Officer Joseph Wolk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results